Flosteron is used as directed by a doctor, adhering to the required dose and method of administration.
Betamethasonum
Glucocorticosteroids
1 ml suspension contains:
Active components:
Betamethasone (as Betamethasone dipropionate) – 5.00 mg (6.43 mg)
Betamethasone (as Betamethasone sodium phosphate) – 2.00 mg (2.63 mg)
Excipients:Methyl parahydroxybenzoate, Propyl parahydroxybenzoate, Benzyl alcohol, Macrogol (4000), Sodium carmellose, Disodium phosphate dodecahydrate, Disodium edetate, Sodium chloride, Polysorbate 80, Hydrochloric acid (1 M solution), Water for injection.
Corticosteroid therapy is adjunctive therapy and does not replace general treatment.
Betamethasone is indicated for the treatment of various rheumatological, dermatological, allergic diseases, systemic connective tissue diseases, and other diseases where a response to corticosteroid treatment is usually observed.
As supportive short-term therapy (in the acute form or exacerbation of the disease) for osteoarthritis, rheumatoid arthritis.
In dermatological diseases.
As supportive short-term therapy (in the acute form or exacerbation of an existing disease) for bursitis on the background of solid calluses, heel spurs, limited motion of the big toe or deformation of the big toe, synovial cyst, Morton’s metatarsalgia, tenosynovitis, periostitis of the cuboid type bone.
Bronchial asthma, asthmatic status.
Seasonal or perennial allergic rhinitis.
Severe form of allergic bronchitis, contact dermatitis, atopic dermatitis, hay fever.
Angioneurotic edema, serum sickness.
Hypersensitivity reactions to medicinal products or insect bites.
Osteoarthritis, rheumatoid arthritis.
Bursitis, lumbago, sciatica, coccydynia, acute gouty arthritis.
Wry neck (torticollis), ganglion cyst, ankylosing spondylitis, radiculitis, exostosis, fasciitis.
Atopic dermatitis (discoid eczema), neurodermatitis (circumscribed neurodermatitis), contact dermatitis, severe solar dermatitis, urticaria.
Hypertrophic lichen planus, diabetic necrobiosis lipoidica.
Alopecia areata, discoid lupus erythematosus, psoriasis, keloid scars.
True pemphigus, dermatitis herpetiformis, cystic acne.
For the exacerbation and as maintenance treatment of some types of disseminated systemic lupus erythematosus, polyarteritis nodosa, scleroderma, and dermatomyositis.
As palliative therapy for leukemia and lymphoma in adults.
In acute leukemia in children.
Shake the ampoule before use!The medicinal product Protazon must not be administered intravenously or subcutaneously!The dose is selected individually, according to the patient's needs, the type of disease, its severity, and the patient's body reaction.The dose should be minimal, and the duration of administration should be as short as possible. The initial dose should be selected until a satisfactory clinical effect is achieved. If a sufficient clinical effect is not achieved after an adequate period, the treatment should be discontinued by gradually reducing the dose of the medicinal product, and other appropriate treatment should be administered. With a satisfactory effect, it is necessary to determine the optimal dose by reducing the initial dose (at permissible time intervals) until the minimum dose that ensures an adequate clinical effect is reached.
